GET THE APP

Pattern of Fungal Infection in Post COVID-19 Patients: A Narrative Review | Abstract

Journal of Research in Medical and Dental Science
eISSN No. 2347-2367 pISSN No. 2347-2545

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Pattern of Fungal Infection in Post COVID-19 Patients: A Narrative Review

Author(s): Kisha Gupta and Sarika Dakhode*

Abstract

COVID-19 is caused by the new Severe Acute Respiratory Coronavirus COV 2 (SARS-CoV-2) which was labelled a worldwide outbreak even by The World Health Organization on January 30, 2020. The pandemic has hit 213 nations and territories as of August 20, with about 22 256 219 confirmed cases worldwide. Patients with underlying illnesses have a poor prognosis for the disease, with comorbidities documented in a substantial percentage of hospitalised and severe cases. According to preliminary data, older people and people with pre-existing diseases including chronic obstructive pulmonary disease, cardiovascular disease, cancer and diabetes mellitus, are more vulnerable to extreme COVID-19 than others.

Coronavirus are a broad group of viruses that can cause a variety of lung diseases in human beings, from mild to severe. CoV-2, or severe acute respiratory syndrome, is an infective and pathogenic Coronavirus that first appeared towards the end of 2019 and has subsequently produced a pandemic of acute respiratory illness known as "Coronavirus disease 2019", which is a global health issues. Its complaints can vary from a simple cough to more extreme disorders like bronchitis, pneumonia, ARDS, MODS, and can be fatal. COVID-19 is known to have rapid and serious advancement in those with already existing health issues, often resulting to death. SARS-CoV-2 infected a huge number of people worldwide, causing cold, cough, chest pain, dyspnoea, and individuals with additional ailments are at the greatest chances of developing the disease. Mucormycosis, Aspergillosis, Cryptococcosis, candidiasis as comorbidities in COVID-19 sufferers are discussed in detail in the review.

Share this article